NABP expressed its support for federal legislation that would distinguish between compounding and manufacturing, in testimony presented at a United States House subcommittee hearing on May 23, 2013. 

Illinois would establish a four-year medical marijuana pilot program under a bill passed by the state’s Legislature and under review by Illinois Governor Pat Quinn.

Pharmacists in Pennsylvania would be granted authority to vaccinate patients above the age of seven with a parent’s consent under two bills being considered by the Pennsylvania General Assembly. 

DEA has issued a final order temporarily placing three synthetic cannabinoids into Schedule I of the Controlled Substances Act (CSA). 

National Association of Boards of Pharmacy ^® (NABP^®) has expressed its support for the Pharmaceutical Compounding Quality and Accountability Act.

Under a contract with the New Jersey Division of Consumer Affairs and the state’s Attorney General Jeffrey S. Chiesa, NABP will assist the Division with inspections of New Jersey pharmacies engaged in the practice of compounding. 

Reaching a critical milestone in the generic Top-Level Domain (gTLD) approval process, the National Association of Boards of Pharmacy^® (NABP^®) application to own and operate the .PHARMACY domain suffix has passed the Internet Corporation for Assigned Names and Numbers (ICANN) initial evaluation.

Delegates to the NABP 109th Annual Meeting elected individuals to fill the president-elect, treasurer, and open member positions on the Association’s 2013-2014 Executive Committee. 

NABP honored leaders in the protection of public health at the 109^th Annual Meeting. 

The Missouri Board of Pharmacy will be allowed to test drugs in pharmacy inventories under a new law.

Drug Enforcement Administration (DEA) is offering two regional one-day Pharmacy Diversion Awareness Conferences (PDAC) in the Chicago, IL, area, one on Saturday, June 22, 2013, and another on Sunday, June 23, 2013. 

Delegates to the National Association of Boards of Pharmacy^® (NABP^®) 109^th Annual Meeting, held May 18-21, 2013, in St Louis, MO, elected individuals to fill the president-elect, treasurer, and open member positions on the Association’s 2013-2014 Executive Committee.

The National Association of Boards of Pharmacy^® (NABP^®) honored leaders in the protection of public health at the Association’s 109^th Annual Meeting, held May 18-21, 2013, in St Louis, MO.

Delegates from the member boards of pharmacy adopted eight resolutions during the National Association of Boards of Pharmacy^® (NABP^®) 109^th Annual Meeting, held May 18-21, 2013, in St Louis, MO. 

Karen M. Ryle, MS, RPh, began her term as president of the National Association of Boards of Pharmacy^® (NABP^® ) during the Final Business Session of the Association’s 109^th Annual Meeting, May 18-21, 2013, in St Louis, MO. 

Joseph L. Adams, RPh, was elected to serve as the 2013-2014 president-elect of the National Association of Boards of Pharmacy^® (NABP^®) during the Association’s 109^th Annual Meeting, May 18-21, 2013, in St Louis, MO. 

Edward G. McGinley, MBA, RPh, was elected to serve as the 2013-2014 treasurer of the National Association of Boards of Pharmacy^® (NABP^®) during the Association’s 109^th Annual Meeting, May 18-21, 2013, in St Louis, MO. 

James T. DeVita, RPh, was reelected to serve a second three-year member term, representing District 1, on the Executive Committee of the National Association of Boards of Pharmacy^® (NABP^®) during the Association’s 109^th Annual Meeting, May 18-21, 2013, in St Louis, MO.

Susan Ksiazek, RPh, was elected to serve a three-year member term, representing District 2, on the Executive Committee of the National Association of Boards of Pharmacy^® (NABP^®) during the Association’s 109^th Annual Meeting, May 18-21, 2013, in St Louis, MO.

Gary Dewhirst, RPh, was elected to serve a three-year member term, representing District 5, on the Executive Committee of the National Association of Boards of Pharmacy^® (NABP^®) during the Association’s 109^th Annual Meeting, May 18-21, 2013, in St Louis, MO. 

Each year the National Association of Boards of Pharmacy^® (NABP^®) Executive Committee selects an individual to serve as its honorary president for the coming year. 

Michael A. Burleson, RPh, immediate past president of the National Association of Boards of Pharmacy^® (NABP^®), assumed the office of chairperson of the Association’s 2013-2014 Executive Committee during the Final Business Session of the NABP 109^th Annual Meeting, held May 18-21, 2013, in St Louis, MO. 

Reaching a critical milestone in the generic Top-Level Domain (gTLD) approval process, the National Association of Boards of Pharmacy^® (NABP^®) application to own and operate the .PHARMACY domain suffix has passed the Internet Corporation for Assigned Names and Numbers (ICANN) initial evaluation. 

The 2012-2013 Committee on Constitution and Bylaws met via teleconference on April 10, 2013.

In testimony presented at a United States Senate Committee Hearing, NABP expressed its support of draft legislation that would create a new category of manufacturer to include entities that engage in large-scale production of sterile non-patient-specific drugs for distribution. 

Medications produced and distributed by The Compounding Shop of St Petersburg, FL, should not be administered to patients and should be quarantined, warns FDA. 

The Colorado Electronic Prescription Drug Monitoring Program has now deployed the NABP PMP InterConnect^®, bringing the total number of live participating state prescription monitoring programs (PMPs) to 15.

The complete pharmacy acts and regulations of Guam, Puerto Rico, and the Virgin Islands are now included in NABPLAW ^® Online.

To further protect the integrity of the United States drug supply chain, the National Association of Boards of Pharmacy^® (NABP^®) has updated the criteria for the Association’s Verified-Accredited Wholesale Distributors^® (VAWD^®) accreditation program. 

The United States Pharmacopeia (USP) General Chapter <17> Prescription Container Labeling, published in the USP 36–NF 31, became an official standard on May 1, 2013.

Federal lawmakers have drafted legislation that would create a new category of drug compounders, “compounding manufacturers,” to be regulated by Food and Drug Administration (FDA). 

The Drug Enforcement Administration's (DEA) sixth National Prescription Drug Take-Back Day on April 27, 2013, collected twice the amount of unneeded and expired medications for safe disposal than the previous DEA take-back event six months ago.

Best practices for pharmacy security guidelines have been developed by the New Jersey State Board of Pharmacy and the state’s Attorney General to assist pharmacies in preventing drug theft and diversion. 

To further protect the integrity of the United States drug supply chain, the National Association of Boards of Pharmacy^® (NABP^®) has updated the criteria for the Association’s Verified-Accredited Wholesale Distributors^® (VAWD^®) accreditation program. 

Effective July 1, 2013, the application fees for the Foreign Pharmacy Graduate Examination Committee (FPGEC) certification, which includes taking the Foreign Pharmacy Graduate Equivalency Examination (FPGEE), will increase.

Teen abuse of prescription drugs has increased, in part driven by teens' and parents' attitudes toward stimulant abuse, indicates the latest Partnership Attitude Tracking Study.

Fraudulent, unapproved versions of Botox^® are being sold by unlicensed suppliers to US medical practices, warns FDA. 

The National Association of Boards of Pharmacy^® (NABP^®) recently issued a report emphasizing that the global distribution of counterfeit and substandard medications, fueled by illegal online sellers, demands an international response.

Two pharmacies have voluntarily recalled their sterile compounded products because of concerns associated with quality control processes and a lack of sterility assurance. 

A bill to strengthen the regulation of compounding pharmacies in Maine was introduced to the state’s legislature.